Pfizer Inc.
LFA3 VARIANTS AND COMPOSITIONS AND USES THEREOF

Last updated:

Abstract:

The invention provides LFA3 polypeptide molecules, e.g., variant LFA3 fusion polypeptide molecules. The invention includes uses, and associated methods of using the LFA3 polypeptide molecules.

Status:
Application
Type:

Utility

Filling date:

28 Sep 2020

Issue date:

4 Feb 2021